Literature DB >> 11821760

The learning curve revisited: stapedotomy.

Eric W Sargent1.   

Abstract

OBJECTIVE: To determine whether the outcome of stapedotomy changes with experience. STUDY DESIGN AND
SETTING: Retrospective case review of an academic otologic practice of a fellowship-trained otologist that consisted of 50 consecutive patients who underwent primary stapedotomy. The main outcome measures were preoperative and postoperative audiograms for both the operated ear and the opposite ear (control).
RESULTS: There were no major complications or loss of hearing among the 50 patients. Minor complications included 1 middle ear infection, 2 torn flaps, and 1 tympanic membrane perforation. One patient had worse conductive hearing loss after surgery. The hearing of 2 patients was unchanged. Hearing for the entire group improved (P > 0.001) from a speech reception threshold of 55 dB (SD, 17 dB) to 30 dB (SD, 19 dB). Complete closure of the air-bone gap was achieved in 20% of the first 10 patients and 30% of the last 10 patients.
CONCLUSIONS: The results of stapedotomy improve with experience, although the learning curve seems less steep than has been reported for total or near-total footplate removal. SIGNIFICANCE: Stapedotomy can be successfully performed early in surgical experience, but the learning curve should be acknowledged and discussed with the patient.

Entities:  

Mesh:

Year:  2002        PMID: 11821760     DOI: 10.1067/mhn.2002.121517

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Can the learning curve in stapes surgery predict future functional outcome?

Authors:  B Sergi; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-04-29       Impact factor: 2.124

2.  Impact of surgeons' experience and the single-shot perioperative antibiotic prophylaxis on outcome in stapedotomy.

Authors:  Faris F Brkic; Boban M Erovic; Arina Onoprienko; Stefan Janik; Dominik Riss; Claudia Lill; Stefan Grasl; Jafar-Sasan Hamzavi; Erich Vyskocil
Journal:  PLoS One       Date:  2021-02-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.